GlassScriptPhysician profile
Omayra L Gonzalez
NPI 1053304279
$23,485.47
in general payments reported to CMS, 2019-2025
57 companies · $4,958 in 2025
The $4,958 reported for 2025 was more than what 82% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,792 · 2020: $1,971 · 2021: $2,569 · 2022: $3,516 · 2023: $3,850 · 2024: $3,829 · 2025: $4,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,373.25 |
| Education | $264.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $3,076.42 | 2019-2025 | Darzalex, Erleada, Rybrevant |
| Astrazeneca Pharmaceuticals LP | $2,809.54 | 2019-2025 | Tagrisso, Lynparza, Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $2,513.15 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Abbvie INC. | $1,828.12 | 2019-2025 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $1,543.31 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Merck Sharp & Dohme LLC | $1,444.09 | 2019-2025 | Keytruda, Welireg, Keytruda Qlex |
| Amgen INC. | $1,367.41 | 2019-2025 | Xgeva, Kyprolis, Lumakras |
| Genentech USA, INC. | $1,201.47 | 2019-2025 | Polivy, Tecentriq, Lunsumio |
| Pbg Puerto Rico LLC | $899.24 | 2019-2025 | |
| Puma Biotechnology, INC. | $576.24 | 2019-2025 | |
| Genzyme Corporation | $474.47 | 2019-2025 | |
| Pharmaessentia USA Corporation | $429.15 | 2022-2025 | Besremi |
| Incyte Corporation | $346.22 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Alexion Pharmaceuticals, INC. | $292.26 | 2022-2025 | Ultomiris |
| Astellas Pharma US INC | $270.84 | 2021-2025 | Xospata, Padcev, Vyloy |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $267.63 | 2019-2025 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $251.93 | 2023-2025 | Libtayo |
| Glaxosmithkline, LLC. | $246.99 | 2022-2025 | Jemperli, Zejula, Ojjaara |
| Medtronic, INC. | $245.58 | 2022-2025 | Corevalve Evolut R |
| Sobi, INC | $244.89 | 2023-2025 | |
| Taiho Oncology, INC. | $234.52 | 2019-2024 | |
| Rigel Pharmaceuticals, INC. | $216.63 | 2021-2023 | Tavalisse, Rezlidhia |
| Telix Pharmaceuticals | $211.06 | 2025 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $184.43 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $172.19 | 2021-2025 | |
| Genmab U.S., INC. | $157.03 | 2023-2025 | Epkinly |
| Janssen Biotech, INC. | $145.98 | 2021-2024 | Erleada |
| Seagen INC. | $139.22 | 2022-2023 | Tukysa |
| Clovis Oncology, INC. | $137.91 | 2019-2022 | |
| Caris Mpi, INC. | $125.86 | 2025 | Mi Cancer Seek |
| Beigene USA, INC. | $110.72 | 2021-2025 | Brukinsa |
| Verity Pharmaceuticals INC. | $109.24 | 2023-2024 | Trelstar, Akynzeo |
| Bayer Puerto Rico INC. | $105.12 | 2023-2025 | Nubeqa, Vitrakvi, Stivarga |
| Gilead Sciences, INC. | $100.48 | 2021-2025 | Trodelvy |
| Tempus Ai, INC | $96.88 | 2024 | Xt Cdx |
| Mirati Therapeutics, INC. | $88.94 | 2023-2024 | Krazati |
| Sanofi-Aventis U.S. LLC | $81.00 | 2023 | |
| Eisai INC. | $80.60 | 2019-2025 | |
| Pfizer INC. | $76.74 | 2019-2025 | |
| Lilly USA, LLC | $73.85 | 2020-2021 | |
| Octapharma USA, INC. | $59.47 | 2019 | |
| Pharmaand Gmbh | $49.93 | 2025 | Rubraca |
| Emd Serono, INC. | $45.68 | 2023-2024 | Bavencio |
| Pfizer Pharmaceuticals LLC | $45.68 | 2019 | |
| Kite Pharma, INC. | $41.76 | 2019 | |
| Tolmar, INC. | $40.45 | 2025 | Rubraca, Eligard |
| Actelion Pharmaceuticals US, INC. | $25.61 | 2022 | |
| Fennec Pharmaceuticals, INC. | $24.98 | 2025 | Fyarro |
| Organon LLC | $23.42 | 2025 | |
| Springworks Therapeutics, INC. | $23.39 | 2025 | Ogsiveo |
| Beone Medicines USA, INC. | $21.64 | 2025 | Brukinsa |
| Adaptive Biotechnologies Corporation | $20.31 | 2025 | Clonoseq |
| Spectrum Pharmaceuticals INC. | $18.94 | 2019 | |
| Celgene Corporation | $18.85 | 2019 | |
| Johnson and Johnson International | $16.81 | 2020 | |
| Ferring Pharmaceuticals INC. | $16.25 | 2025 | Adstiladrin |
| Karyopharm Therapeutics INC. | $14.95 | 2023 | Xpovio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omayra Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.